EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis

医学 观察研究 类风湿性关节炎 风湿病 临床试验 关节炎 物理疗法 炎性关节炎 系统回顾 痹症科 内科学 重症监护医学 梅德林 政治学 法学
作者
Kulveer Singh Mankia,Heidi J. Siddle,Andreas Kerschbaumer,D. Alpizar-Rodriguez,Anca I. Catrina,Juan de Dios Cañete,Andrew P. Cope,C. Daïen,Kevin D. Deane,Hani S. El-Gabalawy,Axel Finckh,Vernon Michael Holers,Marios Koloumas,Francesca Ometto,Karim Raza,Condruta Zabalan,Annette H M van der Helm–van Mil,Dirkjan van Schaardenburg,Daniel Aletaha,Paul Emery
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:80 (10): 1286-1298 被引量:75
标识
DOI:10.1136/annrheumdis-2021-220884
摘要

BACKGROUND: Despite growing interest, there is no guidance or consensus on how to conduct clinical trials and observational studies in populations at risk of rheumatoid arthritis (RA). METHODS: An European League Against Rheumatism (EULAR) task force formulated four research questions to be addressed by systematic literature review (SLR). The SLR results informed consensus statements. One overarching principle, 10 points to consider (PTC) and a research agenda were proposed. Task force members rated their level of agreement (1-10) for each PTC. RESULTS: Epidemiological and demographic characteristics should be measured in all clinical trials and studies in at-risk individuals. Different at-risk populations, identified according to clinical presentation, were defined: asymptomatic, musculoskeletal symptoms without arthritis and early clinical arthritis. Study end-points should include the development of subclinical inflammation on imaging, clinical arthritis, RA and subsequent achievement of arthritis remission. Risk factors should be assessed at baseline and re-evaluated where appropriate; they include genetic markers and autoantibody profiling and additionally clinical symptoms and subclinical inflammation on imaging in those with symptoms and/or clinical arthritis. Trials should address the effect of the intervention on risk factors, as well as progression to clinical arthritis or RA. In patients with early clinical arthritis, pharmacological intervention has the potential to prevent RA development. Participants' knowledge of their RA risk may inform their decision to participate; information should be provided using an individually tailored approach. CONCLUSION: These consensus statements provide data-driven guidance for rheumatologists, health professionals and investigators conducting clinical trials and observational studies in individuals at risk of RA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Hugo完成签到,获得积分10
1秒前
ohooo发布了新的文献求助10
1秒前
ku发布了新的文献求助10
1秒前
大模型的应助被FXQ采纳,获得10
1秒前
wddd333333完成签到,获得积分10
1秒前
南楼发布了新的文献求助10
2秒前
2秒前
高铭泽发布了新的文献求助10
3秒前
shuyiWang发布了新的文献求助10
5秒前
儒雅青梦完成签到,获得积分10
5秒前
小鹿飞飞发布了新的文献求助10
5秒前
lvy发布了新的文献求助10
7秒前
甫贤180949174完成签到,获得积分20
7秒前
7秒前
彭于晏的应助被开心德地采纳,获得10
7秒前
VV完成签到,获得积分10
7秒前
Yxianzi发布了新的文献求助10
7秒前
8秒前
111发布了新的文献求助10
8秒前
今后的应助被超级无敌采纳,获得10
8秒前
8秒前
ku完成签到,获得积分10
9秒前
科研通AI6.2的应助被Xu采纳,获得20
9秒前
stresm完成签到,获得积分10
10秒前
10秒前
852的应助被碧蓝跳跳糖采纳,获得10
10秒前
科研通AI6.3的应助被jjjwwww采纳,获得10
10秒前
orixero的应助被开心德地采纳,获得10
11秒前
FaFa发布了新的文献求助10
11秒前
秋风的应助被jiajiajia采纳,获得10
11秒前
kalani发布了新的文献求助10
12秒前
12秒前
13秒前
13秒前
科研通AI6.3的应助被pokexuejiao采纳,获得10
13秒前
13秒前
Hello的应助被开心德地采纳,获得10
14秒前
15秒前
15秒前
LongH2完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189302
求助须知:如何正确求助?哪些是违规求助? 9576666
关于积分的说明 21849295
捐赠科研通 7787245
什么是DOI,文献DOI怎么找? 3435521
关于科研通互助平台的介绍 2559748
邀请新用户注册赠送积分活动 2482509